Atlas Trials

A Study of Peginterferon Alfa-2a [PEGASYS] in Patients With Chronic Hepatitis B Who Are HBeAg Positive

Clinical trial NCT01086085 · COMPLETED

Trial details

NCT number
NCT01086085
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis B, Chronic
Start date
2010-04-01
Primary completion
2013-03-01
Enrollment
265

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.